Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis
Although the sensitivity and specificity of the Duke criteria for the diagnosis of infective
endocarditis (IE) have been validated by investigators from Europe and the United States, several …
endocarditis (IE) have been validated by investigators from Europe and the United States, several …
[HTML][HTML] Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
M Gao, RE Nettles, M Belema, LB Snyder, VN Nguyen… - Nature, 2010 - nature.com
The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estimated to be
approaching 200 million people 1 . Current therapy relies upon a combination of pegylated …
approaching 200 million people 1 . Current therapy relies upon a combination of pegylated …
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in …
Antiretroviral therapy can reduce human immunodeficiency virus type 1 (HIV-1) viremia to
below the detection limit of ultrasensitive clinical assays (50 copies of HIV-1 RNA/ml). However…
below the detection limit of ultrasensitive clinical assays (50 copies of HIV-1 RNA/ml). However…
Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART
RE Nettles, TL Kieffer, P Kwon, D Monie, Y Han… - Jama, 2005 - jamanetwork.com
ContextMany patients infected with human immunodeficiency virus type 1 (HIV-1) and
receiving highly active antiretroviral therapy experience intermittent episodes of detectable …
receiving highly active antiretroviral therapy experience intermittent episodes of detectable …
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
…, L Rong, ND Sansone, RE Nettles… - Proceedings of the …, 2013 - National Acad Sciences
… We denote by R(a) the concentration of intracellular vRNA in a cell that has been infected
for time a. In the absence of treatment, R(a) may be described by , where α represents the rate …
for time a. In the absence of treatment, R(a) may be described by , where α represents the rate …
[PDF][PDF] Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS‐790052 in humans: in …
…, X Huang, B Kienzle, M Bifano, RE Nettles… - …, 2011 - Wiley Online Library
The NS5A replication complex inhibitor, BMS‐790052, inhibits hepatitis C virus (HCV)
replication with picomolar potency in preclinical assays. This potency translated in vivo to a …
replication with picomolar potency in preclinical assays. This potency translated in vivo to a …
Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads
TL Kieffer, MM Finucane, RE Nettles… - The Journal of …, 2004 - academic.oup.com
Human immunodeficiency virus (HIV) production continues in patients receiving highly active
antiretroviral therapy (HAART) with undetectable (<50 copies/mL) virus loads. Our initial …
antiretroviral therapy (HAART) with undetectable (<50 copies/mL) virus loads. Our initial …
[PDF][PDF] Multiple ascending dose study of BMS‐790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
RE Nettles, M Gao, M Bifano, E Chung, A Persson… - …, 2011 - Wiley Online Library
The antiviral activity, resistance profile, pharmacokinetics (PK), safety, and tolerability of
BMS‐790052, a nonstructural protein 5A (NS5A) replication complex inhibitor, were evaluated in …
BMS‐790052, a nonstructural protein 5A (NS5A) replication complex inhibitor, were evaluated in …
G→A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4+ T Cells In Vivo
TL Kieffer, P Kwon, RE Nettles, Y Han, SC Ray… - Journal of …, 2005 - Am Soc Microbiol
In vitro studies have shown that the host cytidine deaminase APOBEC3G causes lethal
hypermutation in human immunodeficiency virus type 1 reverse transcripts unless its …
hypermutation in human immunodeficiency virus type 1 reverse transcripts unless its …
HIV-1 viral load blips are of limited clinical significance
…, TL Kieffer, RF Siliciano, RE Nettles - Journal of Antimicrobial …, 2006 - academic.oup.com
… Nettles et al. recently published data from a prospective analysis of blips using frequent
viral load sampling (every 2–3 days) for 3–4 months in a group of 10 HIV-infected individuals. …
viral load sampling (every 2–3 days) for 3–4 months in a group of 10 HIV-infected individuals. …
